| Literature DB >> 22791108 |
Abstract
Continuing glucose monitoring (CGM) is a relatively new and rapidly developing technology that shows promise for the future management of type 1 diabetes. When used with near-daily frequency, it has a significant effect on improvement of glucose metabolism as measured by HbA1C and reduction of hypoglycemia. It appears to be safe and actually reduces both DKA and severe hypoglycemia. Early studies indicate that it should be cost effective.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22791108 DOI: 10.1007/s11892-012-0303-6
Source DB: PubMed Journal: Curr Diab Rep ISSN: 1534-4827 Impact factor: 4.810